Massimo Chessa, MD, PhD

Transcatheter Closure of Congenital and Acquired Muscular Ventricular Septal Defects Using the Amplatzer¬Æ Device

08/01/2008

Surgical closure of congenital or acquired [post-myocardial infarction (MI)] muscular ventricular septal defects (MVSD) is still associated with significant mortality and long-term morbidity.1,2 Different surgical approaches have been...

Surgical closure of congenital...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Initial Experience with the New Amplatzer¬Æ Duct Occluder II

08/17/2009

Gianfranco Butera , MD, PhD;

Mario Carminati , MD;

Massimo Chessa , MD, PhD;

Jaspal Dua , MBBS, DCH, MRCPCh, MD;

Luciane Piazza , MD;

Diana Negura , MD;

Angelo Micheletti , MD;

Claudio Bussadori , MD;

ABSTRACT: Background. Different devices are used for trans-catheter occlusion of patent ductus arteriosus (PDA), each with its own limitations and complications. We report our initial single-center experience with the new Amplatzer® Duct...

ABSTRACT: Background. Different...

08/17/2009

Journal of Invasive Cardiology

Rapid Communication

Preliminary Experiences Closing Secundum Atrial Septal Defect Using the Modified Cardia Intrasept‚Ñ¢ Device

08/01/2008

Massimo Chessa , MD, PhD;

Gianfranco Butera , MD, PhD;

Mario Carminati , MD;

The secundum type atrial septal defect is the fourth most common congenital heart defect, with an incidence of 3.78 per 10,000 live births,1 corresponding to 5.9% of the diagnosed congenital heart disease in children.2 Over the past decade,...

The secundum type atrial...

08/01/2008

Journal of Invasive Cardiology